| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2025 | Dec, 2025 |
| Sales | 57,080 | 59,000 | 49,580 | 0 | 0 |
| Sales Growth | -3.25% | +19.00% | unch | unch | unch |
| Net Income | -7,060 | -80 | -14,110 | 0 | 0 |
| Net Income Growth | -8,725.11% | +99.43% | unch | unch | unch |
Shl Telemedicine Ltd ADR (SHLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
SHL Telemedicine Ltd is engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Its solutions for healthcare professionals include: CHF monitoring service which supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease and Readmission Solutions for reducing heart-related readmissions. SHL Telemedicine Ltd is based in Israel.
Fiscal Year End Date: 12/31